{
    "physical_examinations": [
        {
            "date": "Not specified",
            "vital_signs": "Height: 133.2 cm (SDS -2.91); Blood glucose: 17.7 mmol/liter (RR 3.5–5.5); Plasma IGF-I: 772 ng/ml (RR 166–646); Insulin: 77 pmol/liter, C-peptide: 0.64 nmol/liter (RR 0.2–0.65); Average hemoglobin A1c: 6.6-9.9%",
            "relevant_findings": "Dysmorphic facial features: broad nasal bridge, synophrys, prominent epicanthii, lowset ears, thin upper lip, high arched palate, and small opalescent teeth. Mild global developmental delay. Low bone mineral content (SDS -2.9).",
            "changes_over_time": "Patient's height increased from 72.2 cm (at age 3.4 yr) to 133.2 cm (at age 20.3 yr), and A1c levels ranged significantly with insulin treatment. Other findings remained consistent."
        },
        {
            "date": "Not specified",
            "vital_signs": "Height: 89.2 cm (SDS -3.4); Birth weight: 1.8 kg (SDS -3.2); Height at 5 yr: 92 cm (SDS -3.75).",
            "relevant_findings": "Dysmorphic facial features, left convergent strabismus, fifth finger clinodactyly, multiple café-au-lait lesions, congenital scalp epidermal cyst.",
            "changes_over_time": "Height increased marginally from 89 cm (at 4.4 yr) to 92 cm (at 5 yr) before diagnosis of lymphoma; significant clinical deterioration leading to death at age 5.7 yr."
        }
    ]
}